Spring, 2009

Spring 2009

Hello everyone!  I would like to thank all of you who attended the Spring Meeting in Myrtle Beach. The Marriott Grand Dunes was very nice. Steve did an outstanding job inviting all of our speakers and coordinating the meeting.   I heard so many attendees this year say they were going to apply what they had learned in the meeting when they returned home. This is one of the many reasons why attending meetings is so important to our field.  It allows you to have the ability to advance in the field, and fine tune the skills you have already acquired. I would also like to thank the vendors for their continued support of the society.  For those who could not attend we missed you, but we have the Fall Meeting at the Friday Center in Chapel Hill to look forward to.  It will be held September 26th, 2009.

I am very excited about this upcoming year.  I want to continue to grow and provide exceptional speakers for our meetings. We are going to continue to use the website, web blast, and on-line newsletters to keep you up to date with the society.    We need your continued support and the support of non-members to join. The board, as well as myself, are available to answer any questions or comments. Have a great springtime!


Budd-Chiari Syndrome: An Overview of the Symptoms, Diagnosis, and Treatment
Sonography 130
Instructor: Alice Bradley
Heather Campbell D’Apice
Fall 2008


This paper will give an overview of Budd-Chiari Syndrome, a rare disease affecting 1 in 100,000 individuals worldwide (Aydinli and Bayraktar, 2007). This disease occurs when the hepatic veins or inferior vena cava are blocked by either congenital or acquired means. The three main symptoms include hepatomegaly, ascites, and abdominal pain (Hoekstra and Janssen, 2008). Color and pulsed Doppler ultrasound are useful in diagnosing this syndrome. Treatment options include: anticoagulant therapy, percutaneous transluminal angioplasty with a stent, liver shunts, and transplantation (Pahuriray, Alpert & Kowalkski, 2007). The prognosis of this disease is variable, and studies place the 5-year survival rate at 65-69% and the 10-year survival rate at 57-62% (Hoekstra and Janssen, 2008; Pahuriray, Alpert & Kowalkski, 2007)

Tina Cole

1.  How long have you been in the field of Sonography?  What are your 
registered specialties?
I have been working in the field of Sonography for ~17 years.  I am registered in Abd, OB/GYN, and vascular.

2. What is your educational background?
I began my educational career at Johnston Community College in Smithfield earning an A.A.S in Radiologic Science, then headed to UNC Chapel Hill to earn a B.S. in Radiologic Science, traveled to Winston-Salem to earn A.A.S from Forsyth Technical Community College in Sonography, and finally completed my M.H.A from Pfeiffer University in Charlotte last summer.

3. What positions have you held on the NCUS board?
Newsletter Editor and President

This edition of the NCUS Newsletter is a very special one.  First of all, the entire NCUS Board of Director’s would like to openly thank Steven Penny for a job well done during his term, and also Allison Grant for accepting the role as our new president!  In addition, we would like to thank all of you who attended the Spring Meeting in Myrtle Beach, helpers, vendors, and attendees alike.  It was a great success and we are excited about the Fall Meeting in Chapel Hill as well.  Please make plans now to attend that meeting on September 26th, 2009. 

Real-time 3-Dimensional Color Doppler Flow of Mitral and Tricuspid 
Regurgitation: Feasibility and Initial Quantitative Comparison with 
2-Dimensional Methods 

Which technology quantifies the severity of the regurgitation better: 2-dimensional or 3-dimensional methods? The article “Real-time 3-Dimensional Color Doppler Flow of Mitral and Tricuspid Regurgitation: Feasibility and Initial Quantitative Comparison with 2-Dimensional Methods” from the Journal of American Society of Echocardiography compares data collected from conventional 2D methods with 3D technology. This article was chosen because 3 dimension technology is the future of echocardiography and it is interesting to see how 2-dimension versus 3 dimension when quantifying mitral and tricuspid regurgitation.